We study the prevalence and impact of autoantibodies on vascular dysfunction in healthy COVID-19 survivors, revealing elevated anti-ACKR1 autoantibodies associating with systemic cytokines and endothelial dysfunction. This evidence concerns the gene ACKR1 and COVID-19.